In Outbreak Wake, Should Regulations Of Compounding Pharmacies Change?

BOSTON — Documents newly released by the state Department of Public Health show the Framingham pharmacy at the center of the national meningitis outbreak repeatedly violated state drug regulations, but was never severely punished by the state.

The violations include mass producing drugs in violation of its license, and telling health providers to give the names of nurses instead of patients when submitting orders for drugs.

The documents show complaints were filed as far back as a decade ago against New England Compounding Center.

The outbreak has raised questions about whether there should be changes to federal and state regulations over compounding pharmacies, which specialize in retooling medications for individual patients.

For a look at this, Daniel Carpenter, a political science professor at Harvard University who specializes in regulatory law, joined Morning Edition Tuesday.

Please follow our community rules when engaging in comment discussion on wbur.org.
  • robertthebrused

    One thing that has been largely
    overlooked is that the New England Compounding Center had numerous
    complaints filed against it between 2004 and 2006 (during Mitt
    Romney’s term as Governor of Massachusetts). These complaints could
    have, and should have resulted in NECC’s bankruptcy, but Romney’s
    administration seems to have put company profit above public health.

Most Popular